Learning disability

Sierra School of Solano County Moves to Facility in Fairfield, California

Retrieved on: 
Thursday, September 8, 2022

Programming at Sierra School of Solano County is designed to meet the unique academic and social-emotional learning needs of each individual student.

Key Points: 
  • Programming at Sierra School of Solano County is designed to meet the unique academic and social-emotional learning needs of each individual student.
  • Starting the 2022-2023 school year in a new building is an exciting milestone for our faculty, staff and students, said Jenelle Droke, director of Sierra School of Solano County.
  • The new Sierra School facility includes Sierra Caf, a coffee shop designed to give students the experience and guidance needed to succeed in the workforce.
  • For more information on services and enrollment at Sierra School of Solano County, please visit https://sesischools.com/locations/california/sierra-school-of-solano-cou... .

Excite Reading™ Wins 2022 Tech & Learning Award of Excellence in Primary Education

Retrieved on: 
Thursday, September 8, 2022

PRINCETON, N.J., Sept. 8, 2022 /PRNewswire/ -- Learning Ally, a leading nonprofit education solutions provider working to improve reading outcomes in U.S. schools, has won a 2022 Tech & Learning "Back to School" Award of Excellence in Primary Education for its new Excite Reading.™

Key Points: 
  • PRINCETON, N.J., Sept. 8, 2022 /PRNewswire/ -- Learning Ally, a leading nonprofit education solutions provider working to improve reading outcomes in U.S. schools, has won a 2022 Tech & Learning "Back to School" Award of Excellence in Primary Education for its new Excite Reading .
  • Excite Reading is a Prek-2nd Grade supplemental reading program that takes a holistic approach to early childhood literacy.
  • Excite Reading stories come from Learning Ally's rich e-library of vibrant, culturally responsive titles to engage emergent readers through human narration.
  • "Thank you Tech & Learning for acknowledging Excite Reading as a beneficial instructional resource in primary education," adds Ms. Wiederstein.

Former U.S. Congressman Don Manzullo's New Book Focuses on Americans' Distrust of Congress and ways to Restore Faith in Democracy

Retrieved on: 
Tuesday, September 6, 2022

ROCKFORD, Ill., Sept. 6, 2022 /PRNewswire/ -- Former Congressman, Don Manzullo (R-IL), knows about navigating the often tumultuous and stalemated U.S. Congress.

Key Points: 
  • ROCKFORD, Ill., Sept. 6, 2022 /PRNewswire/ -- Former Congressman, Don Manzullo (R-IL), knows about navigating the often tumultuous and stalemated U.S. Congress.
  • In his new book, Do Nice Guys Run for Congress?
  • Relying on his faith and determination, Manzullo overcame political headwinds and a severe learning disability to help change the perception that members of Congress are corrupt and unable to work together.
  • While his friendly bipartisan style is missed in the halls of Congress, it comes alive on the pages of this book," added U.S.

Government of Canada invests in foundational skills training and support for workers on Prince Edward Island

Retrieved on: 
Thursday, August 25, 2022

Now, more than ever, it's critical that workers have the foundational and transferable skills they need to adapt, and thrive in the evolving workforce of today.

Key Points: 
  • Now, more than ever, it's critical that workers have the foundational and transferable skills they need to adapt, and thrive in the evolving workforce of today.
  • This $59.9 million investment through the Skills for Success program will provide skills training for over 52,000 Canadians.
  • La Factry's Canada Cratif project, which will implement a training program that will assist 375 French-speaking newcomers across Canada to develop their socio-emotional skills.
  • Announced in Budget 2021, the Government of Canada is investing nearly $298M over three years in the Skills for Success Program.

Specialized Education Services, Inc. Names Rachael Chatel 2022 Teacher of the Year

Retrieved on: 
Thursday, June 9, 2022

SESIs inaugural Teacher of the Year (TOY) program honors educators who exemplify high-quality, evidence-based instruction and the importance of equitable education for all SESI students.

Key Points: 
  • SESIs inaugural Teacher of the Year (TOY) program honors educators who exemplify high-quality, evidence-based instruction and the importance of equitable education for all SESI students.
  • We are thrilled to recognize Rachael as our first Teacher of the Year.
  • Employed with the High Road School of Hartford since 2020, Chatel works diligently to support her students IEP goals.
  • It is an incredible honor being named SESIs Teacher of the Year, said Chatel.

Learning Ally Announces Student Recipients of the 2022 National Achievement Awards

Retrieved on: 
Thursday, June 9, 2022

PRINCETON, N.J., June 9, 2022 /PRNewswire/ -- Learning Ally, a national nonprofit with a mission of "literacy for all" in U.S. schools, has announced the student winners of its 2022 National Achievement Awards.

Key Points: 
  • Scholarships Recognize Students with Learning Disabilities and Blind and Visual Impairments Who Demonstrate Exemplary Academic Progress, Self-Advocacy, and Community Service
    PRINCETON, N.J., June 9, 2022 /PRNewswire/ -- Learning Ally, a national nonprofit with a mission of "literacy for all" in U.S. schools, has announced the student winners of its 2022 National Achievement Awards .
  • Each student recipient receives a $3,000 to $6,000 endowed scholarship named for two longtime advocates of the organization Marion Huber and Mary P. Oenslager.
  • Students selected for the National Achievement Awards are exceptional role models.
  • Recipients of the 2022 Marion Huber Learning Through Listening Award (LTL) are:

Neuronascent Receives FDA Orphan Drug Designation for NNI-351 Treatment of Fragile X Syndrome

Retrieved on: 
Wednesday, June 1, 2022

ROCKVILLE, Md., June 01, 2022 (GLOBE NEWSWIRE) -- Neuronascent Inc, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for the companys NNI-351 treatment of Fragile X Syndrome.

Key Points: 
  • ROCKVILLE, Md., June 01, 2022 (GLOBE NEWSWIRE) -- Neuronascent Inc, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for the companys NNI-351 treatment of Fragile X Syndrome.
  • This Orphan Drug Designation follows closely on Neuronascents recent receipt of the Rare Pediatric Drug Designation by the FDA, suggesting the agencys support for novel therapies to treat young patients with Fragile X Syndrome, a rare disorder that affects less than 200,000 patients in the United States.
  • Fragile X Syndrome is an inherited, X-linked disorder, predominantly found in males, and is a major cause of intellectual disabilities and autism.
  • NNI-351 could therefore potentially slow and even reverse these behavioral deficits in young and young adults with Fragile X Syndrome.

The University of Arizona Global Campus Spring 2022 Commencement

Retrieved on: 
Thursday, May 26, 2022

CHANDLER, Ariz., May 26, 2022 /PRNewswire/ -- The University of Arizona Global Campus (UAGC) welcomed more than 1,000 graduates and 5,000 guests to McKale Memorial Center May 22 on the University of Arizona campus in Tucson for the first in-person Commencement ceremony since becoming UAGC in December 2020 and since the start of the COVID-19 pandemic. In all, the UAGC spring 2022 graduate total, whether they attended the Commencement or not, was 5,673.

Key Points: 
  • CHANDLER, Ariz., May 26, 2022 /PRNewswire/ -- The University of Arizona Global Campus (UAGC) welcomed more than 1,000 graduates and 5,000 guests to McKale Memorial Center May 22 on the University of Arizona campus in Tucson for the first in-person Commencement ceremony since becoming UAGC in December 2020 and since the start of the COVID-19 pandemic.
  • In all, the UAGC spring 2022 graduate total, whether they attended the Commencement or not, was 5,673.
  • In all, the UAGC spring 2022 graduate total, whether they attended the Commencement or not, was 5,673.
  • Editor's note: Interviews can be arranged with Angela, Kenneth and Mauri to learn more about their experiences attending and graduating from the University of Arizona Global Campus.

The University of Arizona Global Campus Spring 2022 Commencement

Retrieved on: 
Thursday, May 26, 2022

CHANDLER, Ariz., May 26, 2022 /PRNewswire/ -- The University of Arizona Global Campus (UAGC) welcomed more than 1,000 graduates and 5,000 guests to McKale Memorial Center May 22 on the University of Arizona campus in Tucson for the first in-person Commencement ceremony since becoming UAGC in December 2020 and since the start of the COVID-19 pandemic. In all, the UAGC spring 2022 graduate total, whether they attended the Commencement or not, was 5,673.

Key Points: 
  • CHANDLER, Ariz., May 26, 2022 /PRNewswire/ -- The University of Arizona Global Campus (UAGC) welcomed more than 1,000 graduates and 5,000 guests to McKale Memorial Center May 22 on the University of Arizona campus in Tucson for the first in-person Commencement ceremony since becoming UAGC in December 2020 and since the start of the COVID-19 pandemic.
  • In all, the UAGC spring 2022 graduate total, whether they attended the Commencement or not, was 5,673.
  • In all, the UAGC spring 2022 graduate total, whether they attended the Commencement or not, was 5,673.
  • Editor's note: Interviews can be arranged with Angela, Kenneth and Mauri to learn more about their experiences attending and graduating from the University of Arizona Global Campus.

Neuronascent Receives FDA Rare Pediatric Drug Designation for NNI-351 Treatment for Fragile X Syndrome

Retrieved on: 
Tuesday, May 24, 2022

ROCKVILLE, Md., May 24, 2022 (GLOBE NEWSWIRE) -- Neuronascent Inc., a clinical-stage biopharmaceutical company discovering and developing neuron-generating therapies for rare developmental disorders, today announced that the US Food and Drug Administration (FDA) granted rare pediatric designation for NNI-351 for Fragile X syndrome.

Key Points: 
  • ROCKVILLE, Md., May 24, 2022 (GLOBE NEWSWIRE) -- Neuronascent Inc., a clinical-stage biopharmaceutical company discovering and developing neuron-generating therapies for rare developmental disorders, today announced that the US Food and Drug Administration (FDA) granted rare pediatric designation for NNI-351 for Fragile X syndrome.
  • Fragile X syndrome (FXS) is a heritable monogenic disorder and is a major cause of intellectual disabilities and autism.
  • With a marketing application for NNI-351 for young FXS patients, Neuronascent as sponsor will request an award of a rare pediatric disease priority voucher.
  • The receipt of this rare pediatric designation from the FDA allows Neuronascent to become eligible for the pediatric priority review voucher, which provides significant value to our first-in-class therapeutic NNI-351 for FXS in young individuals, stated founder and CEO, Judith Kelleher-Andersson, PhD.